Sectors · Healthcare & Life Sciences

Biotech / Pharma

Private financing across Biotech / Pharma, aggregated from public sources.

Biotech / Pharma is a subsector of Healthcare & Life Sciences. Zoom out to read the whole macro sector $400.1B raised across 15,264 companies.

$5.7B
Capital raised
227
Companies
476
Rounds
2008
First on record
2026-03-19
Latest round

Cooling Biotech / Pharma drew $131.8M over the last 12 months, down 69% versus the prior 12 ($420.1M). Of 202 companies rankable against same-niche peers, 23% model over-valued and 27% under-valued.

Capital flow over time

Quarterly capital raised across Biotech / Pharma.

2008-Q4 · $39.9M2008-Q42009-Q2 · $3.1M2009-Q3 · $6.6M2009-Q4 · $13.9M2010-Q2 · $2.5M2010-Q4 · $2.2M2011-Q1 · $5.3M2011-Q12011-Q3 · $13.5M2011-Q4 · $8.4M2012-Q1 · $46.8M2012-Q2 · $2.8M2012-Q4 · $2.2M2013-Q1 · $25.0M2013-Q12013-Q2 · $9.1M2013-Q3 · $37.1M2013-Q4 · $12.9M2014-Q1 · $26.8M2014-Q2 · $55.6M2014-Q3 · $25.3M2014-Q32014-Q4 · $49.7M2015-Q1 · $240K2015-Q2 · $51.1M2015-Q3 · $16.7M2015-Q4 · $5.1M2016-Q1 · $21.2M2016-Q12016-Q2 · $43.7M2016-Q3 · $6.5M2016-Q4 · $12.2M2017-Q1 · $23.0M2017-Q2 · $33.9M2017-Q3 · $37.8M2017-Q32017-Q4 · $18.9M2018-Q1 · $33.8M2018-Q2 · $96.6M2018-Q3 · $201.0M2018-Q4 · $102.3M2019-Q1 · $56.5M2019-Q12019-Q2 · $45.0M2019-Q3 · $48.3M2019-Q4 · $79.7M2020-Q1 · $177.8M2020-Q2 · $290.0M2020-Q3 · $102.6M2020-Q32020-Q4 · $172.3M2021-Q1 · $196.7M2021-Q2 · $743.1M2021-Q3 · $262.2M2021-Q4 · $97.0M2022-Q1 · $343.8M2022-Q12022-Q2 · $48.3M2022-Q3 · $153.4M2022-Q4 · $26.8M2023-Q1 · $328.6M2023-Q2 · $84.5M2023-Q3 · $118.1M2023-Q32023-Q4 · $393.0M2024-Q1 · $97.9M2024-Q2 · $152.6M2024-Q3 · $225.1M2024-Q4 · $50.5M2025-Q1 · $88.5M2025-Q12025-Q2 · $56.0M2025-Q3 · $24.4M2025-Q4 · $65.8M2026-Q1 · $41.6M
Median round size by stage
StageMedian roundRounds
Growth/Late$434.5M1
Series D+$51.0M19
Series C$48.1M29
Series B$18.7M83
Series A$5.4M130
Seed$1.9M110
Pre-Seed$317K104
Top-funded companies
CompanyStageRaisedModeled value
Pivot Bio, Inc.
Berkeley
Growth/Late$622.6M$13.0B
Greenlight Biosciences Inc.
Medford
Series D+$179.4M$3.9B
Alto Pharmacy Holdings, Inc.
SAN FRANCISCO
Series D+$169.7M$3.1B
Life Biosciences LLC
BOSTON
Series C$123.4M$2.8B
Colossal Biosciences Inc.
AUSTIN
Series D+$162.6M$2.8B
Imago BioSciences, Inc.
San Carlos
Series C$137.5M$2.7B
Vedanta Biosciences, Inc.
CAMBRIDGE
Series D+$240.3M$2.0B
Seismic Therapeutic, Inc.
Watertown
Series D+$146.3M$1.9B
Sherlock Biosciences, Inc.
BRIGHTON
Series C$112.8M$1.7B
BlueSphere Bio, Inc.
PITTSBURGH
Series C$55.6M$1.5B
Vignette Bio, Inc.
SAN DIEGO
Series D+$105.0M$1.1B
Mantra Bio, Inc.
SAN FRANCISCO
Series B$30.1M$1.1B
Pacific Biosciences Of California, Inc.
MENLO PARK
Series C$190.3M$982.0M
Akoya Biosciences, Inc.
Menlo Park
Series B$33.5M$901.1M
Carbon Biosciences, Inc.
BOSTON
Series B$38.0M$744.8M
Front Range Biosciences, Inc.
LAFAYETTE
Series B$45.0M$689.5M
Sudo Biosciences, Inc.
CARMEL
Series C$73.1M$685.8M
Nido Biosciences, Inc.
Cambridge
Series B$22.4M$637.1M
LifeVault Bio, Inc.
WALTHAM
Series B$17.9M$595.3M
Pharmajet, Inc.
GOLDEN
Series B$66.9M$568.1M
Related sectors

Browse all sectors or the full company rankings.

Frequently asked
How much venture funding has the Biotech / Pharma sector raised?
Companies in Biotech / Pharma have raised approximately $5.7B across 476 recorded financing rounds among 227 companies, aggregated from public sources.
Is Biotech / Pharma venture funding growing?
Biotech / Pharma funding is currently cooling: capital raised over the last 12 months was down 69% versus the prior 12 months.
What is the typical round size in Biotech / Pharma?
Median disclosed round sizes in Biotech / Pharma by stage are: Growth/Late $434.5M, Series D+ $51.0M, Series C $48.1M, Series B $18.7M. These are medians across recorded rounds, not averages.
Which are the most-funded Biotech / Pharma companies?
The most-funded Biotech / Pharma companies in our coverage include Pivot Bio, Inc., Greenlight Biosciences Inc., Alto Pharmacy Holdings, Inc., Life Biosciences LLC, Colossal Biosciences Inc.. See the full ranked table for disclosed capital and modeled valuations.
When did Biotech / Pharma funding activity begin in this data?
The earliest recorded Biotech / Pharma financing in our coverage dates to 2008, with the most recent round around 2026-03-19.
Biotech / Pharma venture funding — $5.7B raised · Provath